Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomized to ANA 20 mg/day, 150 mg/day, or placebo for 2...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Krauss, Ronald M., Wojnooski, Kathleen, Orr, Joseph, Geaney, J. Casey, Pinto, Cathy Anne, Liu, Yang, Wagner, John A., Luk, Julie Mabalot, Johnson-Levonas, Amy O., Anderson, Matt S., Dansky, Hayes M.
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society for Biochemistry and Molecular Biology 2012
Témata:
Patient-Oriented and Epidemiological Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276477/
https://ncbi.nlm.nih.gov/pubmed/22180633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M018010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky